Skip to content
← Full study record

NCT00849251 · MORE INFO

Limitations, agreements, and source contact

Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma · Source last updated 2017-09-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
GT60
restrictive Agreement
true
point Of Contact
email
pbecker@uw.edu
organization
University of Washington
phone
206-616-1589
title
Dr. Pamela Becker
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
GT60
restrictive Agreement
true
point Of Contact
email
pbecker@uw.edu
organization
University of Washington
phone
206-616-1589
title
Dr. Pamela Becker

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice